Hexarelin
The most powerful growth hormone releasing peptide available — it triggers the biggest GH spike of any GHRP. Also uniquely protective for the heart, which has made it interesting for cardiac research. The downside is that its potency comes with more side effects than gentler options like Ipamorelin: it raises cortisol (stress hormone) and prolactin more than any other GHRP, and your body builds tolerance within 2-4 weeks, requiring cycling.
Dosage
100-200 mcg subcutaneous 2-3x daily (must cycle — 2 weeks on, 2 off)
Dosages shown are for research reference only. Always consult a qualified healthcare provider.
Administration
Shop Research-Grade Peptides
99%+ purity · US-based · third-party lab tested
Getting Started — Here's What You'll Need
Effects
GH Release
Highest GH release amplitude among all GHRPs.
Cardioprotection
Unique cardiac benefits through GHS-R1a and CD36 receptor activation.
Recovery
Enhanced GH pulses support faster tissue repair and exercise recovery.
Mechanism of Action
Hexarelin is a synthetic hexapeptide (His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH2) that acts as one of the most potent agonists of the growth hormone secretagogue receptor (GHS-R1a). Its strong receptor affinity produces the highest GH release amplitude among the GHRP family, but this potency comes with broader neuroendocrine activation compared to more selective agents like ipamorelin.
At the pituitary level, hexarelin binding to GHS-R1a activates Gq/11-coupled phospholipase C, generating IP3 and DAG. IP3-mediated calcium release from intracellular stores triggers massive GH vesicle exocytosis. The strong GH response also comes with significant stimulation of cortisol (via ACTH release from corticotrophs) and prolactin release from lactotrophs — side effects that limit its clinical utility compared to more selective secretagogues.
Uniquely among GHRPs, hexarelin demonstrates significant cardioprotective properties independent of GH release. GHS-R1a receptors are expressed on cardiomyocytes, and hexarelin binding activates survival signaling through the PI3K/Akt and ERK1/2 pathways, protecting cardiac cells from ischemia-reperfusion injury and apoptosis. Hexarelin also binds to the scavenger receptor CD36 on macrophages and cardiac tissue, which may contribute to its anti-atherosclerotic and cardioprotective effects. Animal studies have demonstrated reduced infarct size and improved cardiac function following hexarelin administration. However, a significant practical limitation is desensitization — continuous hexarelin use leads to progressive reduction in GH response within 2-4 weeks, necessitating cycling protocols to maintain effectiveness.
Regulatory Status
Not FDA approved. Research peptide. Studied in clinical trials for GH deficiency and cardiac conditions but not commercially developed.
Risks & Safety
Common
elevated cortisol, elevated prolactin, water retention, increased appetite, headache.
Serious
desensitisation after 2-4 weeks of continuous use, breast tissue growth in men from prolactin elevation.
Rare
severe water retention, wrist pain/numbness.
Compare Hexarelin With
Research Papers
6Published: June 30, 2025
AI Summary
Liver metabolism converts alexamorelin to hexarelin, but hexarelin is not a unique marker since it is sold separately. Detecting alexamorelin itself remains important for doping controls.
Published: December 6, 2023
AI Summary
Computer simulations showed how different permeability enhancers affect peptide release in the gut: hydrophobic peptides were released more while water-soluble ones were held back. These insights could help design better oral peptide formulations.
Published: September 13, 2023
AI Summary
Researchers investigated hexarelin's potential to protect against acute kidney injury from ischemia and reperfusion, and to clarify its mechanisms via the MDM2/p53 pathway.
Published: January 3, 2023
AI Summary
Hexarelin and JMV2894 protected nerve cells from oxidative stress in an ALS model, activating survival pathways. The findings suggest GHS-based drugs could be developed for ALS, though more research is needed.
Published: March 28, 2022
AI Summary
Hexarelin slowed abdominal aortic aneurysm formation in mice by preserving smooth muscle contractility and reducing inflammation driven by NF-kappa-B. The peptide also reduced inflammasome activation and IL-18 production.
Published: June 4, 2021
AI Summary
Chitosan and EDTA increased intestinal absorption of both enalaprilat and hexarelin in rats. Paracellular enhancers worked better than transcellular ones for these hydrophilic peptides; luminal hypotonicity did not affect their absorption.
Frequently Asked Questions
What is Hexarelin?
The most powerful growth hormone releasing peptide available — it triggers the biggest GH spike of any GHRP. Also uniquely protective for the heart, which has made it interesting for cardiac research. The downside is that its potency comes with more side effects than gentler options like Ipamorelin: it raises cortisol (stress hormone) and prolactin more than any other GHRP, and your body builds tolerance within 2-4 weeks, requiring cycling.
What is Hexarelin used for?
The most powerful growth hormone releasing peptide available — it triggers the biggest GH spike of any GHRP. Also uniquely protective for the heart, which has made it interesting for cardiac research. The downside is that its potency comes with more side effects than gentler options like Ipamorelin: it raises cortisol (stress hormone) and prolactin more than any other GHRP, and your body builds tolerance within 2-4 weeks, requiring cycling.
What is the dosage for Hexarelin?
Standard: 100-200 mcg subcutaneous two or three times daily on an empty stomach. Must be cycled — desensitization occurs within 2-4 weeks of continuous use. Typical cycling: 2 weeks on, 2 weeks off.
What are the side effects of Hexarelin?
Common: elevated cortisol, elevated prolactin, water retention, increased appetite, headache. Serious: desensitisation after 2-4 weeks of continuous use, breast tissue growth in men from prolactin elevation. Rare: severe water retention, wrist pain/numbness.
How does Hexarelin work?
Hexarelin is a synthetic hexapeptide (His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH2) that acts as one of the most potent agonists of the growth hormone secretagogue receptor (GHS-R1a). Its strong receptor affinity produces the highest GH release amplitude among the GHRP family, but this potency comes with broader neuroendocrine activation compared to more selective agents like ipamorelin. At the pituitary level, hexarelin binding to GHS-R1a activates Gq/11-coupled phospholipase C, generating IP3 and DAG. IP3-mediated calcium release from intracellular stores triggers massive GH vesicle exocytosis. The strong GH response also comes with significant stimulation of cortisol (via ACTH release from corticotrophs) and prolactin release from lactotrophs — side effects that limit its clinical utility compared to more selective secretagogues. Uniquely among GHRPs, hexarelin demonstrates significant cardioprotective properties independent of GH release. GHS-R1a receptors are expressed on cardiomyocytes, and hexarelin binding activates survival signaling through the PI3K/Akt and ERK1/2 pathways, protecting cardiac cells from ischemia-reperfusion injury and apoptosis. Hexarelin also binds to the scavenger receptor CD36 on macrophages and cardiac tissue, which may contribute to its anti-atherosclerotic and cardioprotective effects. Animal studies have demonstrated reduced infarct size and improved cardiac function following hexarelin administration. However, a significant practical limitation is desensitization — continuous hexarelin use leads to progressive reduction in GH response within 2-4 weeks, necessitating cycling protocols to maintain effectiveness.
How is Hexarelin administered?
Hexarelin is administered via subcutaneous injection.
What is the half-life of Hexarelin?
The half-life of Hexarelin is 1.2 hours.
Is Hexarelin legal?
Not FDA approved. Research peptide. Studied in clinical trials for GH deficiency and cardiac conditions but not commercially developed.
Related Peptides
ACE-031
An experimental drug that acts as a 'decoy' to intercept myostatin and other muscle-limiting signals before they reach your muscles. It produced rapid muscle gains in clinical trials without any exercise. However, development was halted because it also accidentally blocked signals needed to maintain healthy blood vessels, causing nosebleeds and visible broken blood vessels. A powerful proof-of-concept that myostatin blocking works, but too dangerous in its current form.
AICAR
A natural compound that activates your cells' energy sensor — the same pathway that turns on during exercise. Mimics the metabolic effects of endurance exercise at the cellular level, helping with fat burning, glucose uptake, and building more mitochondria. Banned by WADA as a metabolic modulator after detection in professional cycling.
BPC-157
A healing compound made from a protein found in stomach fluid. It's the most studied peptide for tissue repair, with research showing it helps heal tendons, ligaments, muscles, the gut, and other organs. It's stable enough to survive stomach acid, so you can take it either by injection under the skin or by mouth.
BPC-157 + TB-500
A two-in-one product that pairs BPC-157 and TB-500 to target different healing pathways. BPC-157 focuses on gut, tendon, and ligament repair by supporting blood vessel growth and nitric oxide signaling, while TB-500 helps cells move to injury sites for body-wide tissue repair. The most popular peptide combination for healing and recovery.